CoChat

Regulation of Dendritic Cell Migration to the Draining Lymph Node

Open access
Martín-Fontecha, Alfonso, Sebastiani, Silvia, Höpken, Uta E., Uguccioni, Mariagrazia, Lipp, Martin, Lanzavecchia, Antonio, Sallusto, Federica · 2003 · The Journal of Experimental Medicine

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

Abstract

Antigen-pulsed dendritic cells (DCs) are used as natural adjuvants for vaccination, but the factors that influence the efficacy of this treatment are poorly understood. We investigated the parameters that affect the migration of subcutaneously injected mouse-mature DCs to the draining lymph node. We found that the efficiency of DC migration varied with the number of injected DCs and that CCR7+/+ DCs migrating to the draining lymph node, but not CCR7-/- DCs that failed to do so, efficiently induced a rapid increase in lymph node cellularity, which was observed before the onset of T cell proliferation. We also report that DC migration could be increased up to 10-fold by preinjection of inflammatory cytokines that increased the expression of the CCR7 ligand CCL21 in lymphatic endothelial cells. The magnitude and quality of CD4+ T cell response was proportional to the number of antigen-carrying DCs that reached the lymph node and could be boosted up to 40-fold by preinjection of tumor necrosis factor that conditioned the tissue for increased DC migration. These results indicate that DC number and tissue inflammation are critical parameters for DC-based vaccination.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1084/jem.20030448

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Variable efficiency of DC migration to draining lymph node and consequent lymph node congestion. Increasing numbers of CFSE-labeled mature BM-derived DCs were injected into the footpads of syngeneic mice. The total number of DCs recovered in the draining lymph node (LN; A) and the percentage of injected DCs recovered (B) on day 2 is shown. Mean ± SD of three independent experiments is shown, each performed using groups of two mice per condition. (C) Groups of two mice were injected s.c. with increasing numbers of mature DCs. Total cell number in the pooled draining lymph nodes (LN) was measured at different time points. The number of DCs injected was: 2 × 106 (□), 106 (○), 0.5 × 106 (▿), 0.25 × 106 (▵), and 0.125 × 106 (⋄). Mice injected with PBS were used as control (•). The experiment was repeated with comparable results. (D) Mice were injected s.c. with PBS, 106 BM-derived DC (BM-DC), 106 CD11c+ DCs isolated from the spleen or 10 × 106 CD11c− spleen cells that had been labeled with CMTMR. The total cell number in the lymph node (solid bars) and the number of CMTMR+ migrated cells (shaded bars) are shown. One out of three experiments performed is shown. (E) Groups of three mice per condition per time point were injected s.c. with PBS (control), 300 ng TNF, and/or IL-1α, 100 μg LPS, or 106 BM-derived syngeneic DCs from CCR7+/+ or CCR7−/− mice. The total cell number (means ± SD) in the draining lymph node was measured on days 1, 2, and 3.
Figure 1. Variable efficiency of DC migration to draining lymph node and consequent lymph node congestion. Increasing numbers of CFSE-labeled mature BM-derived DCs were injected into the footpads of syngeneic mice. The total number of DCs recovered in the draining lymph node (LN; A) and the percentage of injected DCs recovered (B) on day 2 is shown. Mean ± SD of three independent experiments is shown, each performed using groups of two mice per condition. (C) Groups of two mice were injected s.c. with increasing numbers of mature DCs. Total cell number in the pooled draining lymph nodes (LN) was measured at different time points. The number of DCs injected was: 2 × 106 (□), 106 (○), 0.5 × 106 (▿), 0.25 × 106 (▵), and 0.125 × 106 (⋄). Mice injected with PBS were used as control (•). The experiment was repeated with comparable results. (D) Mice were injected s.c. with PBS, 106 BM-derived DC (BM-DC), 106 CD11c+ DCs isolated from the spleen or 10 × 106 CD11c− spleen cells that had been labeled with CMTMR. The total cell number in the lymph node (solid bars) and the number of CMTMR+ migrated cells (shaded bars) are shown. One out of three experiments performed is shown. (E) Groups of three mice per condition per time point were injected s.c. with PBS (control), 300 ng TNF, and/or IL-1α, 100 μg LPS, or 106 BM-derived syngeneic DCs from CCR7+/+ or CCR7−/− mice. The total cell number (means ± SD) in the draining lymph node was measured on days 1, 2, and 3.CC BY-NC-SA · PubMed Central
Figure 2. The efficiency of DC migration to draining lymph node is increased by TNF, IL-1, and by DCs themselves. (A) PBS or 106 CFSE-labeled DCs were injected into the footpads of syngeneic mice. 24 h later, the mice received a second injection of 106 CMTMR-labeled DCs in the same footpad. Mice were killed 24 h after the second injection and the number of CMTMR+ DCs migrated to the draining lymph nodes was analyzed. (B) The experiment was performed as in A after the injection of PBS, unlabeled 106 DCs, TNF, or IL-1α. Mean of three experiments each performed with groups of two mice per condition is shown. (C) Footpads pretreated with either PBS (•) or TNF (○) were injected with increasing doses of CMTMR-labeled DCs and the number of migrated DCs recovered in the draining lymph node was measured 2 d later. (D) Footpads of mice pretreated with PBS (•), TNF (□), or 106 unlabeled DCs (○) were injected with 106 CMTMR DCs and the number of migrated DCs was evaluated daily. Values are from pooled lymph nodes of two mice per time point. (E) CMFDA was applied to the skin of mice that had been pretreated with either PBS (•) or TNF (○). The number of fluorescent endogenous CD11c+ DCs recovered in the draining lymph node is shown.
Figure 2. The efficiency of DC migration to draining lymph node is increased by TNF, IL-1, and by DCs themselves. (A) PBS or 106 CFSE-labeled DCs were injected into the footpads of syngeneic mice. 24 h later, the mice received a second injection of 106 CMTMR-labeled DCs in the same footpad. Mice were killed 24 h after the second injection and the number of CMTMR+ DCs migrated to the draining lymph nodes was analyzed. (B) The experiment was performed as in A after the injection of PBS, unlabeled 106 DCs, TNF, or IL-1α. Mean of three experiments each performed with groups of two mice per condition is shown. (C) Footpads pretreated with either PBS (•) or TNF (○) were injected with increasing doses of CMTMR-labeled DCs and the number of migrated DCs recovered in the draining lymph node was measured 2 d later. (D) Footpads of mice pretreated with PBS (•), TNF (□), or 106 unlabeled DCs (○) were injected with 106 CMTMR DCs and the number of migrated DCs was evaluated daily. Values are from pooled lymph nodes of two mice per time point. (E) CMFDA was applied to the skin of mice that had been pretreated with either PBS (•) or TNF (○). The number of fluorescent endogenous CD11c+ DCs recovered in the draining lymph node is shown.CC BY-NC-SA · PubMed Central
Figure 3. CCL21 is up-regulated on lymphatic endothelial cells after injection of mature DCs or TNF. Mice were injected intradermally with PBS, 105 syngeneic DCs, or 10 ng TNF. 8 h later, skin samples were collected and embedded in paraffin. Serial sections were stained with hematoxylin and eosin (A–C), or hybridized with antisense (D–F) or sense (inset) 35S-labeled CCL21 riboprobe or stained with a polyclonal antibody to mouse CCL21 (G–I). ×20.
Figure 3. CCL21 is up-regulated on lymphatic endothelial cells after injection of mature DCs or TNF. Mice were injected intradermally with PBS, 105 syngeneic DCs, or 10 ng TNF. 8 h later, skin samples were collected and embedded in paraffin. Serial sections were stained with hematoxylin and eosin (A–C), or hybridized with antisense (D–F) or sense (inset) 35S-labeled CCL21 riboprobe or stained with a polyclonal antibody to mouse CCL21 (G–I). ×20.CC BY-NC-SA · PubMed Central
Figure 4. CCR7−/− DCs fail to migrate to the draining lymph node but efficiently condition the tissue for increased migration of CCR7+/+ DCs. Mice (two per condition) were injected with 106 CCR7+/+ or CCR7−/− syngeneic DCs, TNF, or PBS. 24 h later, all mice received a second injection at the same site of 106 CMTMR-labeled CCR7−/− or CCR7+/+ DCs. The total number of migrated CMTMR-labeled DCs was measured in the draining lymph node after an additional 24 h (gate). Live cells gated as propidium iodide (PI) negative are shown. One of two experiments performed is shown.
Figure 4. CCR7−/− DCs fail to migrate to the draining lymph node but efficiently condition the tissue for increased migration of CCR7+/+ DCs. Mice (two per condition) were injected with 106 CCR7+/+ or CCR7−/− syngeneic DCs, TNF, or PBS. 24 h later, all mice received a second injection at the same site of 106 CMTMR-labeled CCR7−/− or CCR7+/+ DCs. The total number of migrated CMTMR-labeled DCs was measured in the draining lymph node after an additional 24 h (gate). Live cells gated as propidium iodide (PI) negative are shown. One of two experiments performed is shown.CC BY-NC-SA · PubMed Central
Figure 5. Impact of DC migration and tissue conditioning on T cell response. (A) 3 × 106 KJ1–26+ T cells from DO11.10 mice were labeled with CFSE and adoptively transferred into syngeneic BALB/c mice. Control or conditioned mice were primed by injecting OVA323–339–pulsed syngeneic DCs in the footpad. CFSE profiles (day 3) of KJ1.26-gated cells and the absolute number of proliferating T cells after injection of increasing numbers of OVA-pulsed DCs. One representative experiment out of three is shown. (B) CFSE profiles (day 4) of KJ1-26–gated cells and total number of proliferating cells in mice conditioned with PBS, TNF, or 106 syngeneic DCs and primed by 105 OVA-pulsed DCs. Data are from pooled lymph nodes from two mice. (C) CFSE profile (day 4) of KJ1-26–gated T cells and total number of proliferating T cells in control or TNF-conditioned mice primed by 0.1 × 106 or 106 OVA-pulsed CMTMR-labeled DCs. The number of DCs recovered in the same lymph nodes was as follows: nonconditioned, 0.1 × 106 DCs injected, <10; TNF-conditioned, 0.1 × 106 DCs injected, 1,180; nonconditioned, 106 DCs injected, 1,600; TNF-conditioned, 106 DCs injected, 9,320. (D) TNF and IFN-γ production elicited by PMA and ionomycin in KJ1-26–gated cells recovered from draining (top panels) and nondraining (bottom panels) lymph nodes. The total number of cytokine-secreting cells was calculated from the percentage and the total number of cells and is indicated in the dot plot. (E) Mice were challenged by injection of 10 μg OVA in the ear pinna 7 d after priming. Controls include naive mice and mice adoptively transferred with naive DO11.10 T cells (unprimed). Ear thickness was measured 24 h after challenge. One out of two experiments performed is shown.
Figure 5. Impact of DC migration and tissue conditioning on T cell response. (A) 3 × 106 KJ1–26+ T cells from DO11.10 mice were labeled with CFSE and adoptively transferred into syngeneic BALB/c mice. Control or conditioned mice were primed by injecting OVA323–339–pulsed syngeneic DCs in the footpad. CFSE profiles (day 3) of KJ1.26-gated cells and the absolute number of proliferating T cells after injection of increasing numbers of OVA-pulsed DCs. One representative experiment out of three is shown. (B) CFSE profiles (day 4) of KJ1-26–gated cells and total number of proliferating cells in mice conditioned with PBS, TNF, or 106 syngeneic DCs and primed by 105 OVA-pulsed DCs. Data are from pooled lymph nodes from two mice. (C) CFSE profile (day 4) of KJ1-26–gated T cells and total number of proliferating T cells in control or TNF-conditioned mice primed by 0.1 × 106 or 106 OVA-pulsed CMTMR-labeled DCs. The number of DCs recovered in the same lymph nodes was as follows: nonconditioned, 0.1 × 106 DCs injected, <10; TNF-conditioned, 0.1 × 106 DCs injected, 1,180; nonconditioned, 106 DCs injected, 1,600; TNF-conditioned, 106 DCs injected, 9,320. (D) TNF and IFN-γ production elicited by PMA and ionomycin in KJ1-26–gated cells recovered from draining (top panels) and nondraining (bottom panels) lymph nodes. The total number of cytokine-secreting cells was calculated from the percentage and the total number of cells and is indicated in the dot plot. (E) Mice were challenged by injection of 10 μg OVA in the ear pinna 7 d after priming. Controls include naive mice and mice adoptively transferred with naive DO11.10 T cells (unprimed). Ear thickness was measured 24 h after challenge. One out of two experiments performed is shown.CC BY-NC-SA · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 888

Metadata

Authors
Martín-Fontecha, A., Sebastiani, S., Höpken, U. E., Uguccioni, M., Lipp, M., Lanzavecchia, A., & Sallusto, F.
Affiliations
  • 1Institute for Research in Biomedicine, CH-6500 Bellinzona, Switzerland
  • Institute for Research in Biomedicine (CH)
  • 2Max Delbrück Center for Molecular Medicine, 13122 Berlin-Buch, Germany
  • Max Delbrück Center (DE)
Venue
The Journal of Experimental Medicine
Published
2003-08-18
Volume
198
Issue
4
Pages
615-621
ISSN
  • 0022-1007 (ISSN-L)
  • 1540-9538
OpenAlex
W2149057253
Cited by
878
References
29
Citations by year
2026: 9 · 2025: 18 · 2024: 16 · 2023: 24 · 2022: 15 · 2021: 28 · 2020: 27 · 2019: 31 · 2018: 33 · 2017: 37 · 2016: 39 · 2015: 28 · 2014: 29 · 2013: 57 · 2012: 30
FWCI
16.54
Type
journal article
Language
en
Open access
Locations
  • The Journal of Experimental Medicine (publishedVersion)
  • PubMed Central (publishedVersion, cc-by-nc-sa)
  • PubMed (publishedVersion)
  • MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (acceptedVersion)
  • Research Portal (King's College London) (submittedVersion)
Funders
  • National Science Foundation
  • Institute for Research in Biomedicine
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (63885)
  • Helmut Horten Stiftung
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
  • Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Keywords
dendritic cell migration, draining lymph nodes, CCR7, CCL21, lymphatic endothelial cells, inflammatory cytokines, TNF-α, CD4+ T cell responses, antigen-pulsed dendritic cells, dendritic cell vaccine, lymph node cellularity, tissue inflammation
MeSH terms
Animals, Cell Movement, Dendritic Cells, Fluorescent Dyes, Humans, Interleukin-1, Lymph Nodes, Mice, Inbred BALB C, T-Lymphocytes, Tumor Necrosis Factor-alpha, Cell Transplantation, Receptors, Chemokine, Mice, Receptors, CCR7

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.